The Journal of Allergy and Clinical Immunology
Volume 121, Issue 6 , Pages 1379-1384.e1, June 2008

Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women

  • Lucie Blais, PhD

      Affiliations

    • Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada
    • Hôpital du Sacré-Cœur de Montréal, Montreal, Quebec, Canada
    • Corresponding Author InformationReprint requests: Lucie Blais, PhD, Université de Montréal, Faculté de pharmacie, C.P. 6128, succursale Centre-ville, Montreal, Quebec H3C 3J7, Canada.
  • ,
  • Amélie Forget, MSc

      Affiliations

    • Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada
    • Hôpital du Sacré-Cœur de Montréal, Montreal, Quebec, Canada

Received 24 September 2007; received in revised form 27 February 2008; accepted 29 February 2008. published online 14 April 2008.

Background

Uncontrolled maternal asthma during pregnancy has been hypothesized as a cause of congenital malformation, but literature is scare on this topic.

Objective

The aim of this study was to investigate whether asthmatic women who had an exacerbation during the first trimester of pregnancy were more at risk of having a baby with a congenital malformation.

Methods

From the linkage of 3 Canadian administrative databases, we reconstructed a cohort of 4344 pregnancies of asthmatic women. Asthma exacerbations were assessed during the first trimester of pregnancy and were defined as a filled prescription for oral corticosteroids, an emergency department visit, or a hospitalization for asthma. Congenital malformations were assessed at birth and during the first year of life of the newborn by using diagnoses recorded in the databases. Generalized estimating equation models were used to estimate adjusted odds ratios of congenital malformations in association with asthma exacerbations.

Results

In the cohort we identified 398 (9.2%) babies with at least 1 malformation and 261 (6.0%) with a major malformation. The crude prevalences of malformations were 12.8% and 8.9%, respectively, for women who had and those who did not have an exacerbation. The adjusted odds ratio for all malformations was 1.48 (95% CI, 1.04-2.09) when comparing women who had and those who did not have an exacerbation. The corresponding figures were 1.32 (95% CI, 0.86-2.04) for major malformations.

Conclusion

Asthma exacerbations during the first trimester of pregnancy were found to significantly increase the risk of a congenital malformation.

Key words: Asthma, pregnancy, exacerbation, congenital malformations, cohort study, administrative health databases

Abbreviations used: ED, Emergency department, GEE, Generalized estimating equation, ICD-9, International Classification of Diseases–9th Revision, ISQ, Institut de la statistique du Québec, OR, Odds ratio, RAMQ, Régie de l'assurance-maladie du Québec

 

 L. Blais is the recipient of a Salary Award from the Fonds de la recherché en santé du Québec (FRSQ) and is the Endowment Pharmaceutical Chair AstraZeneca in Respiratory Health. This study was funded through grants received from the Fonds de la recherche en santé du Québec (FRSQ), the Canadian Institutes of Health Research (CIHR), and the Canadian Foundation for Innovation.

 Disclosure of potential conflict of interest: L. Blais has received research support from AstraZeneca, Amgen, and GlaxoSmithKline. A. Forget has declared that she has no conflict of interest.

PII: S0091-6749(08)00521-6

doi:10.1016/j.jaci.2008.02.038

The Journal of Allergy and Clinical Immunology
Volume 121, Issue 6 , Pages 1379-1384.e1, June 2008